(H028) Addition of a Targeted Gene Fusion Assay into Myeloid NGS Enables Detection of Cytogenetically Cryptic, Disease-Defining AML Gene Fusions

Poster Presenter(s)

• 

  Corey Post, MD, MS

  Molecular Genetic Pathology Fellow
  University of Michigan
  Ann Arbor, Michigan, United States